280 related articles for article (PubMed ID: 16112768)
1. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never.
Hiatt JR; Carmody IC; Busuttil RW
J Hepatol; 2005 Oct; 43(4):573-7. PubMed ID: 16112768
[No Abstract] [Full Text] [Related]
2. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course!
Broelsch CE; Frilling A; Malago M
J Hepatol; 2005 Oct; 43(4):569-73. PubMed ID: 16120470
[No Abstract] [Full Text] [Related]
3. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series.
Sugawara Y; Tamura S; Makuuchi M
Dig Dis; 2007; 25(4):310-2. PubMed ID: 17960065
[TBL] [Abstract][Full Text] [Related]
4. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
[No Abstract] [Full Text] [Related]
5. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
Kaido T; Takada Y; Uemoto S
Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
[No Abstract] [Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
[TBL] [Abstract][Full Text] [Related]
7. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
[No Abstract] [Full Text] [Related]
8. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: the controversies continue.
Lee HS
Dig Dis; 2007; 25(4):296-8. PubMed ID: 17960062
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation in patients who have received pretransplant treatment for hepatocellular carcinoma.
Yoshizumi T; Shirabe K; Soejima Y; Taketomi A; Ikegami T; Uchiyama H; Harada N; Ijichi H; Maehara Y
Transplantation; 2011 Apr; 91(8):e61-2. PubMed ID: 21475066
[No Abstract] [Full Text] [Related]
11. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Kim IH; Yi NJ; Lee KU
Surgery; 2007 May; 141(5):598-609. PubMed ID: 17462459
[TBL] [Abstract][Full Text] [Related]
12. Comparison between human-telomerase reverse transcriptase mRNA and alpha-fetoprotein mRNA as a predictive value for recurrence of hepatocellular carcinoma in living donor liver transplantation.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Hara Y; Waguri N; Suda T; Aoyagi Y; Hatakeyama K
Transplant Proc; 2006 Dec; 38(10):3636-9. PubMed ID: 17175353
[TBL] [Abstract][Full Text] [Related]
13. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.
Ito T; Takada Y; Ueda M; Haga H; Maetani Y; Oike F; Ogawa K; Sakamoto S; Ogura Y; Egawa H; Tanaka K; Uemoto S
Liver Transpl; 2007 Dec; 13(12):1637-44. PubMed ID: 18044766
[TBL] [Abstract][Full Text] [Related]
14. Editorial on "a revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor liver transplantation in hepatocellular carcinoma".
Lo CM
Surgery; 2007 Jul; 142(1):119-20. PubMed ID: 17630008
[No Abstract] [Full Text] [Related]
15. Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation.
Hwang S; Lee SG; Ahn CS; Kim KH; Moon DB; Ha TY; Park KM; Song GW; Jung DH; Kim BS; Moon KM
Transplant Proc; 2007 Jun; 39(5):1526-9. PubMed ID: 17580180
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.
Takada Y; Ito T; Ueda M; Sakamoto S; Haga H; Maetani Y; Ogawa K; Ogura Y; Oike F; Egawa H; Uemoto S
Dig Dis; 2007; 25(4):299-302. PubMed ID: 17960063
[TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplantation for hepatocellular carcinoma: current status in Korea.
Lee SG; Moon DB; Shin H; Kim KH; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
Transplant Proc; 2012 Mar; 44(2):520-2. PubMed ID: 22410060
[No Abstract] [Full Text] [Related]
18. Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program.
Sotiropoulos GC; Malagó M; Molmenti EP; Radtke A; Fouzas I; Beckebaum S; Saner FH; Paul A; Lang H; Broelsch CE
Dig Dis Sci; 2010 Mar; 55(3):872-3. PubMed ID: 19294504
[No Abstract] [Full Text] [Related]
19. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for hepatocellular carcinoma in children.
Sevmis S; Karakayali H; Ozçay F; Canan O; Bilezikci B; Torgay A; Haberal M
Pediatr Transplant; 2008 Feb; 12(1):52-6. PubMed ID: 18186889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
